Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Deficiency Disorder

Explore clinical trials studying Primary Immune Deficiency Disorder. Study availability and eligibility vary by location and protocol.

21 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Deficiency Disorder trial results

Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

NCT04197596

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +6 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Washington University St Louis, Missouri, United States
  • New York Medical College Vallhala, New York, United States
View Trial Details
Recruiting

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

NCT03266627

Conditions
Adenoviridae Infections, Adenovirus, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • University of Colorado Denver Aurora, Colorado, United States
View Trial Details
Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

NCT03266640

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytomegalovirus Infections, DNA Virus Infections, +8 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Recruiting

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

NCT03266653

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Epstein-Barr Virus Infections, +9 more
Locations
  • Children's Hosptial Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Completed

Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases

NCT03939533

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Scottsdale, Arizona, United States
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site Santa Barbara, California, United States
  • Octapharma Research Site Centennial, Colorado, United States
View all 18 locations
View Trial Details

Related conditions